Key points from article :
British digital health startup PocDoc has secured over $6 million in its latest funding round, bringing its total funding to more than $12 million since its founding in 2020. This funding will support PocDoc’s expansion into international markets and the development of new diagnostic tests targeting metabolic, kidney, and overall health. The company’s mission focuses on transforming access to diagnostics for chronic diseases, particularly cardiovascular, metabolic, and renal (CMR) conditions, which are leading causes of death globally.
Central to PocDoc’s innovation is the Healthy Heart Check, a home test kit that provides a comprehensive cardiovascular risk assessment in under 10 minutes. The technology leverages microfluidic assay (MFA) combined with AI-powered diagnostics to deliver clinical-grade results using a smartphone. PocDoc has integrated this service into the UK’s National Health Service (NHS) digital app, enabling immediate access to cardiovascular health data. Partnerships with UK retailers and pharmacies further support its goal of promoting preventive care and community-based health solutions.
PocDoc’s platform stands out for its ability to perform complex multi-marker diagnostics on-site, eliminating the need for laboratory serum analysis. Its cloud-based infrastructure facilitates data visualization, real-time integration with Electronic Health Records, and population health management. CEO Steve Roest emphasized that early detection and intervention are key to reducing the burden on healthcare systems, noting that the technology has already benefited tens of thousands of patients. With plans for international scaling and new tests in development, PocDoc aims to redefine chronic disease management and prevention.
